NuSirt Biopharma, a company founded by Michael Zemel in Knoxville several years ago, has announced plans to launch a clinical trial to determine if its patented technology is a potential treatment for non-alcoholic fatty liver disease and steatohepatitis. The start-up, now based in Nashville, still maintains its research facilities here. For more information about the trial plans, read the news release. For our three-part series on the company, here are the links: Part 1, Part 2, and Part 3.
"36|86 Entrepreneurship Festival"
- Aug 28 2019
ARC Annual Summit
- Renaissance Asheville Hotel, Asheville, NC
- Sep 04 2019
- Sep 08 2019
- Ts117, 701 Scarboro Road, Oak Ridge
- Sep 10 2019
"Startup Day" Knoxville
- The Mill & Mine, 227 West Depot Avenue, Knoxville
- Sep 24 2019